C
Charles L. Bennett
Researcher at University of South Carolina
Publications - 121
Citations - 2675
Charles L. Bennett is an academic researcher from University of South Carolina. The author has contributed to research in topics: Cancer & Prostate cancer. The author has an hindex of 23, co-authored 121 publications receiving 2294 citations. Previous affiliations of Charles L. Bennett include Beckman Research Institute & William Jennings Bryan Dorn VA Medical Center.
Papers
More filters
Journal ArticleDOI
American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer
J. Douglas Rizzo,Melissa C. Brouwers,Patricia Hurley,Jerome Seidenfeld,Murat O. Arcasoy,Jerry L. Spivak,Charles L. Bennett,Julia Bohlius,Darren Evanchuk,Matthew J. Goode,Ann A. Jakubowski,David H. Regan,Mark R. Somerfield +12 more
TL;DR: Recommendations: ESAs should be avoided in patients with cancer not receiving concurrent chemotherapy, except for those with lower risk myelodysplastic syndromes, and Caution should be exercised when using ESAs with chemotherapeutic agents in diseases associated with increased risk of thromboembolic complications.
Journal ArticleDOI
Systemic Therapy in Men With Metastatic Castration-Resistant Prostate Cancer: American Society of Clinical Oncology and Cancer Care Ontario Clinical Practice Guideline
Ethan Basch,D. Andrew Loblaw,Thomas K. Oliver,Michael A. Carducci,Michael A. Carducci,Ronald C. Chen,James N. Frame,Kristina Garrels,Sebastien J. Hotte,Michael W. Kattan,Derek Raghavan,Fred Saad,Mary-Ellen Taplin,Cindy Walker-Dilks,Cindy Walker-Dilks,James Williams,Eric Winquist,Charles L. Bennett,Ted Wootton,R. Bryan Rumble,Stacie B. Dusetzina,Katherine S. Virgo +21 more
TL;DR: An expert panel to develop evidence-based recommendations informed by a systematic review of the literature concluded that androgen deprivation should be continued indefinitely.
Journal ArticleDOI
Cancer- and chemotherapy-induced anemia
George M. Rodgers,Pamela S. Becker,Charles L. Bennett,David Cella,Asher A. Chanan-Khan,Carolyn M. Chesney,Charles S. Cleeland,Peter F. Coccia,Benjamin Djulbegovic,Jennifer Garst,Jeffrey A. Gilreath,Eric H. Kraut,Weei-Chin Lin,Ursula A. Matulonis,Michael Millenson,Denise K. Reinke,Joseph Rosenthal,Paul Sabbatini,Rowena N. Schwartz,Richard S. Stein,Ravi Vij +20 more
TL;DR: The purpose of these NCCN Guidelines is to operationalize the evaluation and treatment of anemia in adult cancer patients, with an emphasis on those who are receiving concomitant chemotherapy, and to enable patients and clinicians to individualize anemia treatment options based on patient condition.
Journal ArticleDOI
Azithromycin and Levofloxacin Use and Increased Risk of Cardiac Arrhythmia and Death
Gowtham A. Rao,Joshua R. Mann,Azza Shoaibi,Charles L. Bennett,Charles L. Bennett,Georges Nahhas,S Scott Sutton,S Scott Sutton,Sony Jacob,Scott M. Strayer +9 more
TL;DR: A retrospective cohort study among US veterans to test the hypothesis that taking azithromycin or levofloxacin would increase the risk of cardiovascular death and cardiac arrhythmia compared with persons taking amoxicillin, finding that it did so on days 1 to 5 but not 6 to 10.
Journal Article
Amiodarone–Associated Optic Neuropathy: A Review of 294 Cases From the Research on Adverse Drug Events and Reports (RADAR) Project
TL;DR: Research on Adverse Drug events And Reports (RADAR) as discussed by the authors is a clinically based postmarketing surveillance program that systematically investigates and disseminates information describing serious and previously unrecognized adverse drug and device reactions (ADRs).